Healthy Clinical Trial
Official title:
Effects of Dual Task Prioritization Training on Dual Task Walking in Older People: A Single-blinded Randomized Controlled Trial
NCT number | NCT05367128 |
Other study ID # | YM111015F |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | July 25, 2022 |
Est. completion date | June 2023 |
The purpose of this single-blinded three-armed randomized controlled trial is to investigate the effect of different task prioritization during dual task training on dual task performance.
Status | Recruiting |
Enrollment | 39 |
Est. completion date | June 2023 |
Est. primary completion date | June 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 65 Years and older |
Eligibility | Inclusion Criteria: - Age = 65 years old - MMSE scores > 24 Exclusion Criteria: - Unstable health conditions - Any neurological, psychological disease or diagnosis of learning disability which interferes the participation in this study |
Country | Name | City | State |
---|---|---|---|
Taiwan | National Yang Ming Chiao Tung University | Taipei |
Lead Sponsor | Collaborator |
---|---|
National Yang Ming University |
Taiwan,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Dual task walking performance assessment- speed (m/s) | Using GaitUp system to evaluate gait speed during cognitive and motor dual task walking | Change from baseline dual task walking speed and up to 6 weeks (pre- and post-test) | |
Primary | Dual task walking performance assessment- cadence (steps/min) | Using GaitUp system to evaluate cadence during cognitive and motor dual task walking | Change from baseline dual task walking cadence and up to 6 weeks (pre- and post-test) | |
Primary | Dual task walking performance assessment- stride length variability (CV, %) | Using GaitUp system to evaluate stride length variability during cognitive and motor dual task walking | Change from baseline dual task walking stride length variability and up to 6 weeks (pre- and post-test) | |
Primary | Dual task walking performance assessment- stride time variability (CV, %) | Using GaitUp system to evaluate stride time variability during cognitive and motor dual task walking | Change from baseline dual task walking stride time variability and up to 6 weeks (pre- and post-test) | |
Primary | Rate of dual task cost- gait speed (%) | Using the dual and single task walking speed to calculate the dual task cost of gait speed | Change from baseline dual task cost and up to 6 weeks (pre- and post-test) | |
Secondary | Trail Making Test | Use Trail Making Test (TMT)-Chinese version to indicate executive function. The duration for completing the test will be measured, and the shorter duration means the better executive function. | Change from baseline Trail Making Test and up to 6 weeks (pre- and post-test) | |
Secondary | Berg Balance Scale | Use Berg Balance Scale (BBS) to assess balance performance. Berg balance scale scoring ranges from 0 to 56. The higher scores indicate better balance performance. | Change from baseline Berg Balance Scale and up to 6 weeks (pre- and post-test) | |
Secondary | Single task walking performance assessment- speed (m/s) | Using GaitUp system to evaluate gait speed during single walking | Change from baseline single task walking speed and up to 6 weeks (pre- and post-test) | |
Secondary | Single task walking performance assessment- cadence (steps/min) | Using GaitUp system to evaluate cadence during single walking | Change from baseline single task walking cadence and up to 6 weeks (pre- and post-test) | |
Secondary | Single task walking performance assessment- stride length variability (CV, %) | Using GaitUp system to evaluate stride length variability during single walking | Change from baseline single task walking stride length variability and up to 6 weeks (pre- and post-test) | |
Secondary | Single task walking performance assessment- stride time variability (CV, %) | Using GaitUp system to evaluate stride time variability during single walking | Change from baseline dual task walking stride time variability and up to 6 weeks (pre- and post-test) | |
Secondary | Cognitive dual task walking performance assessment- correct number (times) | The number of the correct answer for serially subtracting "7" from a predefined 3-digit number during cognitive dual task walking task will be recorded. | Change from baseline cognitive dual task walking performance and up to 6 weeks (pre- and post-test) | |
Secondary | Motor dual task walking performance assessment- number of go (pieces) | The number of successfully transferred go pieces from one side to another during motor dual task walking task will be recorded. | Change from baseline motor dual task walking performance and up to 6 weeks (pre- and post-test) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |